Nonalcoholic fatty liver disease is the most common liver disease in America. If you have any of these fatty liver symptoms ...

Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.

Experts warn that fatty liver disease (FLD) is becoming an epidemic in India, driven by genetics and lifestyle. With a ...

This article explores how eating junk food raises the risk of fatty liver diseases, examines symptoms, and highlights ...

In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis ...

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.

Liver diseases, both acute and chronic ... the progression from simple steatosis to more severe forms like nonalcoholic ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...